These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

637 related items for PubMed ID: 20450758

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Recent advance in von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
    Zhou J, Li NY, Zhou XJ.
    Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):212-5. PubMed ID: 20450775
    [No Abstract] [Full Text] [Related]

  • 3. A 10-year retrospective study of hemangioblastomas of the central nervous system with reference to von Hippel-Lindau (VHL) disease.
    Padhi S, Sarangi R, Challa S, Bussary P, Panigrahi MK, Purohit AK.
    J Clin Neurosci; 2011 Jul; 18(7):939-44. PubMed ID: 21570297
    [Abstract] [Full Text] [Related]

  • 4. Metastases to hemangioblastomas in von Hippel-Lindau disease.
    Jarrell ST, Vortmeyer AO, Linehan WM, Oldfield EH, Lonser RR.
    J Neurosurg; 2006 Aug; 105(2):256-63. PubMed ID: 17219831
    [Abstract] [Full Text] [Related]

  • 5. Inhibin alpha distinguishes hemangioblastoma from clear cell renal cell carcinoma.
    Hoang MP, Amirkhan RH.
    Am J Surg Pathol; 2003 Aug; 27(8):1152-6. PubMed ID: 12883249
    [Abstract] [Full Text] [Related]

  • 6. Hemangioblastomas and Other Vascular Origating Tumors of Brain or Spinal Cord.
    Vetrano IG, Gioppo A, Faragò G, Pinzi V, Pollo B, Broggi M, Schiariti M, Ferroli P, Acerbi F.
    Adv Exp Med Biol; 2023 Aug; 1405():377-403. PubMed ID: 37452946
    [Abstract] [Full Text] [Related]

  • 7. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease.
    Conway JE, Chou D, Clatterbuck RE, Brem H, Long DM, Rigamonti D.
    Neurosurgery; 2001 Jan; 48(1):55-62; discussion 62-3. PubMed ID: 11152361
    [Abstract] [Full Text] [Related]

  • 8. Stereotactic radiosurgery for intracranial hemangioblastomas: a retrospective international outcome study.
    Kano H, Shuto T, Iwai Y, Sheehan J, Yamamoto M, McBride HL, Sato M, Serizawa T, Yomo S, Moriki A, Kohda Y, Young B, Suzuki S, Kenai H, Duma C, Kikuchi Y, Mathieu D, Akabane A, Nagano O, Kondziolka D, Lunsford LD.
    J Neurosurg; 2015 Jun; 122(6):1469-78. PubMed ID: 25816088
    [Abstract] [Full Text] [Related]

  • 9. Clinical features of patients bearing central nervous system hemangioblastoma in von Hippel-Lindau disease.
    Kanno H, Kuratsu J, Nishikawa R, Mishima K, Natsume A, Wakabayashi T, Houkin K, Terasaka S, Shuin T.
    Acta Neurochir (Wien); 2013 Jan; 155(1):1-7. PubMed ID: 23080552
    [Abstract] [Full Text] [Related]

  • 10. Long-term prognosis of haemangioblastoma of the CNS: impact of von Hippel-Lindau disease.
    Niemelä M, Lemeta S, Summanen P, Böhling T, Sainio M, Kere J, Poussa K, Sankila R, Haapasalo H, Kääriäinen H, Pukkala E, Jääskeläinen J.
    Acta Neurochir (Wien); 1999 Jan; 141(11):1147-56. PubMed ID: 10592114
    [Abstract] [Full Text] [Related]

  • 11. Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences.
    Yousef A, Rutkowski MJ, Yalcin CE, Eren OC, Caliskan I, Tihan T.
    J Neurooncol; 2019 Jul; 143(3):547-552. PubMed ID: 31089924
    [Abstract] [Full Text] [Related]

  • 12. Long-term prognosis of hemangioblastomas of the central nervous system: clinical and immunohistochemical study in relation to recurrence.
    Miyagami M, Katayama Y.
    Brain Tumor Pathol; 2004 Jul; 21(2):75-82. PubMed ID: 15700837
    [Abstract] [Full Text] [Related]

  • 13. Clinicopathological study of vascular endothelial growth factor (VEGF), p53, and proliferative potential in familial von Hippel-Lindau disease and sporadic hemangioblastomas.
    Miyagami M, Katayama Y, Nakamura S.
    Brain Tumor Pathol; 2000 Jul; 17(3):111-20. PubMed ID: 11310918
    [Abstract] [Full Text] [Related]

  • 14. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.
    Muscarella LA, Bisceglia M, Galliani CA, Zidar N, Ben-Dor DJ, Pasquinelli G, la Torre A, Sparaneo A, Fanburg-Smith JC, Lamovec J, Michal M, Bacchi CE.
    Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223
    [Abstract] [Full Text] [Related]

  • 15. PAX2(-)/PAX8(-)/inhibin A(+) immunoprofile in hemangioblastoma: A helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system.
    Carney EM, Banerjee P, Ellis CL, Albadine R, Sharma R, Chaux AM, Burger PC, Netto GJ.
    Am J Surg Pathol; 2011 Feb; 35(2):262-7. PubMed ID: 21263247
    [Abstract] [Full Text] [Related]

  • 16. Characterization of spinal hemangioblastomas in patients with and without von Hippel-Lindau, and YAP expression.
    Calderón-Garcidueñas AL, Piña-Ballantyne SA, Espinosa-Aguilar EJ, de Jesús Ramos-Sánchez R.
    Rev Esp Patol; 2024 Feb; 57(3):160-168. PubMed ID: 38971615
    [Abstract] [Full Text] [Related]

  • 17. Hemangioblastomas of the retina: impact of von Hippel-Lindau disease.
    Niemelä M, Lemeta S, Sainio M, Rauma S, Pukkala E, Kere J, Böhling T, Laatikainen L, Jääskeläinen J, Summanen P.
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1909-15. PubMed ID: 10845616
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. De novo VHL germline mutation detected in a patient with mild clinical phenotype of von Hippel-Lindau disease.
    Ding X, Zhang C, Frerich JM, Germanwala A, Yang C, Lonser RR, Mao Y, Zhuang Z, Zhang M.
    J Neurosurg; 2014 Aug; 121(2):384-386. PubMed ID: 24678776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.